CYP1A1 and CYP2D6 polymorphism and risk of lung cancer in a North Indian population

References

• AGUNDEZ, J. A., GALLARDO, L., LEDESMA, M. C., LOZANO, L., RODRIGUEZ-LESCTJRE, A., PONTES, J. C., IGLESIAS-MORENO, M. C., PocH, J., LADERO, J. M. and BENrrEz, J. 2001, Functionally active duplications of the cyp2d6 gene are more prevalent among larynx and lung cancer patients. Oncology, 61, 59–63.
   Google Scholar
• CASCORBI, I., BROCKMOLIER, J. and ROOTS., I. 1996, A C4887A polymorphism in exon7 of human CYP1A1: population frequency, mutation linkages and impact on lung cancer susceptibility. Cancer Research, 56, 4965 —4969.
   Google Scholar
• CROFTS, E., TATOU, J., TRACHMANN, G. N., COSMA, D., CURIE, P., TONIOLO, S. and GARTE, J. 1993, Functional significance of different human CYP1A1 genotypes. Carcinogenesis, 15, 2961–2963.
   Web of Science ®Google Scholar
• DALY, A. K, CHOLERTON, S., GREGORY, W. and IDLE, J. R. 1993, Metabolic polymorphisms. Pharmacology and Therapeutics, 57, 129–160.
   PubMed Web of Science ®Google Scholar
• FEBBO, P. G., KAN-TOFF, P. W, GIOVANNUCCI, E., BROWN, M., CHANG, G., CHARLES, H. and STAMPFER, M. 1998, Debrisoquine hydroxylase (cyp2d6) and prostrate cancer. Cancer Epidemiology, Biomarkers and Prevention, 7, 1075–1078.
   Google Scholar
• FIELD, J. K, LILOGLOU, T, XINARIANOS, G., PRIME, P., FIELDING, W, WALSHAW, J. M. and TTJRNBULL, L. 1999, Genetic alterations in bronchial lavage as a potential marker for individuals with a high risk of developing lung cancer. Cancer Research, 59, 2690–2695.
   PubMed Web of Science ®Google Scholar
• GAO, Y. and ZHANG, Q. 1999, Polymorphisms of the gstml and cyp2d6 genes associated with susceptibility to lung cancer in Chinese. Mutation Research, 444, 441–449.
   PubMed Web of Science ®Google Scholar
• HAYASHI, S., WATANABE, J. and KAWAJIRI, K 1992, High susceptibility to lung cancer analyzed in terms of combined genotypes of CYP1A1 and Mu class glutathione-S-transferase genes. Japanese Journal of Cancer Research, 83, 866–870.
   Google Scholar
• HIRVONEN, A., PTJRSIANEN, K. H., KARJALAINEN, A., ANTILLA, S. and VANIO, H. 1992, Point mutational MspI and Ile/Val polymorphism closely linked in the CYP1A1 gene; lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiology, Biomarkers and Prevention, 1, 485–489.
   PubMed Web of Science ®Google Scholar
• HONG, Y. S., CHANG, J. H., KWON, 0. J., Hi, Y. A. and Cum, J. J. 1998, Polymorphism of the CYP1A1 and glutathione-S-transferase genes in Korean lung cancer patients. Experimental and Molecular Medicine, 30, 192–198.
   Google Scholar
• KAWAJIRI, K, NAKACHI, K., IMAI, K, Yosim, A., SHINODA, N. and WATANABE, J. 1990, Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of cytochrome P4501A1 gene. FEBS Letters, 263, 131–133.
   PubMed Web of Science ®Google Scholar
• KIYOHARA, C., NAKANISHI, Y, INuTsuKA, S., TAKAYAMA, K, HARA, N., TANAKA, K., KONO, S. and HIROHATA, T. 1998, The relationship between CYP1A1 and aryl hydrocarbon hydroxylase activity and lung cancer in a Japanese population. Pharmacogenetics, 8, 315–323.
   PubMedGoogle Scholar
• LAFOREST, L., WIKMAN, H., BENHAMOU, S., SAARIKOSKI, S. T., BOTJCHARDY, C., HIRVONEN, A., DAYER, P. and HUSGAFVEL-PURSIANEN, K 2000, Cyp2d6 gene polymorphism in Caucasian smokers: lung cancer susceptibility and phenotype-genotype relationships. European Journal of Cancer, 36, 1825–1832.
   Google Scholar
• LE MARCHAND, L., SIVARAMAN, L., PIERCE, L., SEIFRIED, A., Lum, A., WILKENS, L. R and LAU, A. F. 1998, Association of CYP1A1, GSTM1, and CYP2E1 polymorphisms with lung cancer suggest cell type specificities to tobacco carcinogens. Cancer Research, 58, 4858–4863.
   PubMed Web of Science ®Google Scholar
• NAKACHI, K, IMAI, K., HAYASHI, S., WATANABE, J. and KAWAJIRI, K. 1991, Genetic susceptibility to squamous cell carcinoma of the lung in relation to tobacco smoking dose. Cancer Research, 51, 5177–5180.
   PubMed Web of Science ®Google Scholar
• NAKACHI, K, IMAI, K., HAYASHI, S. and KAWAJIRI, K. 1993, Polymorphisms of the CYP1A1 and glutathione-S-transferase genes associate with susceptibility to lung cancer in relation to cigarette dose in Japanese population. Cancer Research, 53, 2994–2998.
   PubMed Web of Science ®Google Scholar
• NAKACHI, K, HAYASHI, S., KAWAJIRI, F. K and IMAI, K. 1995, Association of cigarette smoking and CYP1A1 polymorphism with adenocarcinoma of the lung by grades of differentiation. Carcinogenesis, 16, 2209–2213.
   PubMed Web of Science ®Google Scholar
• NERBERT, D. W. 1991, Role of genetics and drug metabolism in human cancer risks. Mutation Research, 247, 67–281.
   Google Scholar
• OKADA, T., KAWASHIMA, K, Fulusmi, S., MINAKUCHI, T. and NISHIMURA, S. 1994, Association between a cytochrome P450 CYP1A 1 genotype and incidence of lung cancer. Pharmacogenetics, 4, 333–340.
   PubMedGoogle Scholar
• QUINONES, L., LUCAS, D., GODOY, J., CACERES, D., BERTHOU, F., VARELA, N., LEE, K, ACEVEDO, C., MARTINEZ, L, AGUILERA, A. M. and GIL, L 2001, CYP1A1, CYP2E1 and GSTM1 genetic polymorphisms. The effect of single and combined genotypes on lung cancer susceptibility in Chilean people. Cancer Letters, 174, 35–4.
   Google Scholar
• RANNUG, A., ALEXADRIE, A. K, PERSSON, I. and INGELMAN-SUNDBERG, M. 1995, Genetic polymorphism of cytochromes P450 lal, 2d6 and 2e1: regulation and toxicological significance. Journal of Occupational and Environmental Medicine, 37, 25–36.
   Google Scholar
• ROOTS, I., BROCKMOLLER, J., DRAKOULIS, N. and LODDENKEMPER, R. 1992, Mutant genes of cytochrome P-450II d6, glutathione-S- transferase class Mu and arylamine N-acetyl transferase in lung cancer patients. Clinical Investigation, 70, 307–319.
   PubMedGoogle Scholar
• SHAW, G. L., FALK, R T., FRAME, J. N., WEIFFENBACH, B., NESBITT, J. C., PASS, H. I., CAPORASO, N. E., Mom, D. T. and TUCKER, M. A. 1998, Genetic polymorphism of cyp2d6 and lung cancer risk. Cancer Epidemiology, Biomarkers and Prevention, 7, 215–219.
   PubMed Web of Science ®Google Scholar
• SHIELDS, P. G., CAPORASO, N. E., FM, R. I., SUGIMURA, H., TRIVERS, G. E., TRUMP, B. F., HOOVER, R N., WESTON, A. and HARRIS, C. C. 1993, Lung cancer, race and a CYP1A1 genetic polymorphism. Cancer Epidemiology. Biomarkers and Prevention, 2, 581–485.
   PubMed Web of Science ®Google Scholar
• SIVARAMAN, L, LEATHAM, M. P., YEE, J., WILKENS, R, LAU, L. A. F. and LE MARCHAND, L 1994, CYP1A1 genetic polymorphisms and in situ colorectal cancer. Cancer Research, 54, 3692–3695. SONG, N., TAN, W, XING, D. and Lm., D. 2001, CYP1A1 polymorphism and risk to lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis, 22, 11–16.
   Google Scholar
• SREELEKHA, K, RAMADAS, M., PANDEY, G., THOMAS, K R, NAL1NAKIJMARI, M. and PILEAL R. 2001, Genetic polymorphism of CYP1A1, GSTM1 and GSTT1 genes in Indian oral cancer. Oral Oncology, 37, 593–598.
   Google Scholar
• STRAUSS, G. M. 1997, Measuring effectiveness of lung cancer screening: from consensus to controversy and back. Chest, 112 (Supplement 4), 216S–228S.
   Web of Science ®Google Scholar
• STUCKER, I., COSME, J., LAURENT, P., CENEE, S., BEAUNE, P. and BIGNON, J. 1995, cyp2d6 genotype and lung cancer risk according to histologic type and tobacco exposure. Carcinogenesis, 16, 2759–2764.
   PubMed Web of Science ®Google Scholar
• STJGIMTJRA, H., WAKAI, K, GENKA, K, NAGURA, K, IGARASHI, H., NAGAYAMA, H., OHKAWA, A., BABA, S., MORRIS, B. J., TSUGANE, S., OHNO, Y, GAO, C., Li, Z., TAKEZAKI, T., TAJIMA, K and IWAMASA, T. 1998, Association of 11e-462-Val (exon 7) polymorphism of cytochrome P4501a1 with lung cancer in the Asian population: further evidence from a case-control study in Okinawa. Cancer Epidemiology, Biomarkers and Prevention, 7, 413–417.
   Google Scholar
• TEFRE, T., RYBERG, D., HALTGEN, A., NERBET, D. W., SKATJG, V. and BROGGER, A. 1991, Human CYP1A1 gene: lack of association between the MspI restriction fragment length polymorphism and incidence of lung cancer in a Norwegian population. Pharmacogenetics, 1, 20–25.
   PubMedGoogle Scholar
• WILKINSON, G. R, GUENGERICH, F. P. and BRANCH, R A. 1989, Genetic polymorphism of the 5-mephenytoin metabolism in humans. Journal of Biological Chemistry, 269, 15419–15422.
   Google Scholar
• WOLF, C. R, SMITHY, C. A. D., GOUGH, A. C., MOSS, J. E., VALISS, K A., HOWARD, G., CAREY, F. J., Milis, K., McNEE, W. and CARIVIICHEAL, J. 1992, Relationship between the debrisoquine hydroxylase polymorphism and cancer susceptibility. Carcinogenesis, 13, 1035–1038.
   Google Scholar
• XU, X., KELSEY, K T, WIENCKE, J. K, WAIN, J. C. and CHRisTiANI, D. C. 1996, Cytochrome P450 CYP1A1 MspI polymorphism and lung cancer susceptibility. Cancer Epidemiology, Biomarkers and Prevention, 5, 687–692.
   PubMed Web of Science ®Google Scholar
• ZHANG, Z. Y, FASCO, M. J., HUANG, L., GUENGERICH, P. and KAMINSKY, L. S. 1996, Characterization of purified human recombinant cytochrome P4501A1-11e462 and Va1462: assessment of a role for the rare allele in carcinogensis. Cancer Research, 56, 3926–3933.
   PubMed Web of Science ®Google Scholar